Clinical Trial Update: Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous platelet-rich plasma to improve responsiveness and embryo quality in patients with poor ovarian response during infertility …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Autologous Platelet-Rich Plasma (platelet-rich plasma)

Snippet

Sponsor: Nanjing University | Conditions: Infertility | Phase 2 | Status: UNKNOWN